Study confirms the impact of aspergillosis on the prognosis of critically ill patients with viral pneumonia

Researchers from ICVS published a study in the American Journal of Respiratory and Critical Care Medicine, which assesses the influence of the lung microbiota on the incidence and clinical course of patients diagnosed with influenza-associated aspergillosis (IAPA) or COVID-19 (CAPA), or bacterial superinfections.









